fda warning bpc-157 unapproved peptide 2024 2025 peptides In a major policy shift, the U.S. Food and Drug fda warning bpc-157 not approved
Description
Injections are administered safely and efficiently

The benzyl alcohol acts as a preservative, a bacteriostatic agent that inhibits the growth of most potential contaminants

Coding G61.81 (CIDP) without supporting documentation (nerve conduction studies showing demyelination, clinical response to IVIG, neurology evaluation) is a frequent RAC/OIG audit finding

This can likely point to a particular serotonergic response that is timely related to BPC 157 applications
